This is a dedicated hidden-debt deep dive. All prices intraday June 22, 2026. Credit data from Fitch Ratings, company filings, and the Q1 2026 earnings transcripts cited inline.
For a decade private credit grew from a post-2008 financing niche into a ~$1.7 trillion U.S. (over $2 trillion global) asset class projected by the CFA Institute to hit $4.5 trillion by 2030. The defining feature is also the defining flaw: direct loans carry no market price. Funds value themselves on internal models, usually quarterly. When reality moves faster than the mark, the gap accumulates quietly — until it doesn't.
Between mid-May and today, the gap stopped being quiet:
Here is the number every equity investor is ignoring: ~30% of private-credit BDC portfolios are software & services, versus 4–5% of the U.S. high-yield bond market. That wasn't an accident — software's recurring revenue justified 20x-EBITDA buyouts and aggressive leverage, and direct lenders happily financed it against ARR for not-yet-profitable companies.
AI is now re-rating the unit economics of exactly those businesses faster than the underwriting assumed. S&P 500 software multiples have fallen from ~13x to ~8x revenue over five years; the broader group from ~8x to ~3x. Roughly one-fifth of software debt now trades below 90 cents, and analysts estimate ~$500B of credit exposure to software, the largest chunks held by BDCs. Medallia (Thoma Bravo) is the canonical casualty — financed on a stable-SaaS thesis, now being handed to lenders. A 2027–2028 maturity wall sits on top of it.
The Affordable Care restructuring is the empirical anchor for recovery math: a $1.4B private-credit loan cut ~70%; lenders took the keys; the 2021 sponsor equity (Harvest/Berkshire, $2.7B valuation) was wiped to zero. BCRED had it marked at 69.8c at end-March — directionally correct, but the loan reportedly sat in the high-80s/low-90s for ~18 months before reality forced the write-down. That lag is the whole controversy.
The public BDC market has stopped trusting a single industry mark and started pricing each book individually. That is exactly the environment where discrimination pays. Snapshot (intraday June 22):
| Name | Px | NAV | Disc. to NAV | Yield | Non-accrual (FV) | Signal |
|---|---|---|---|---|---|---|
| OBDC (Blue Owl) | $10.93 | $14.41 | ~24% | 11.4% | 1.0% (declining) | BUY |
| ARCC (Ares) | $18.03 | ~$19.5 | ~8% | 10.6% | low/diversified | ACCUMULATE |
| FSK (FS KKR) | $10.27 | $18.83 | ~45% | 16.4% | 4.2% (rising) | AVOID / spec only |
| TCPC (BlackRock) | $3.33 | $7.07 | ~53% | v.high | DOJ probe | AVOID |
I read the Q1 release and the full earnings call. The bear case is priced; the quality isn't. Key facts:
Trade plan: Entry $10.40–11.00; add sub-$10.50. Target $12.75 (re-rate to ~12% discount) → stretch $13.31. Invalidation: weekly close below $9.80, or a quarter with NEW non-accruals pushing NAV below ~$13.75. Timeframe 6–12 months. Conviction: HIGH (3 signals: 1% declining non-accruals + Baa2 upgrade + PIMCO par bid). Total-return math: ~17% price + 11% yield = ~25–28% if the discount merely normalizes.
The "sleep-at-night" private-credit exposure. ~11x P/E, 10.6% yield, the deepest scale and most diversified book, lower idiosyncratic software risk. Wells Fargo trimmed to Equal-Weight (PT $19) — a fair, not damning, call. ARCC just launched a $1B commercial paper program (funding optionality). Accumulate $17.25–18.25, target $20, invalidation weekly close <$16, 6–12 months. Conviction: MEDIUM-HIGH.
The ~45% discount to $18.83 NAV looks tempting and KKR's $11 tender / preferred / buyback puts a soft floor under it — bulls model 40%+ upside. But I won't dress this up: rising non-accruals (4.2%), a dividend cut, Medallia-style software impairments, and a junk-bond raise to fund defense are the profile of a book the market rightly distrusts. The marks are the question, and FSK's are moving the wrong way. Only for risk-tolerant capital sizing it as a sponsor-backstop special situation, not income. If you must, the KKR backstop frames the floor near $10–11; I'd rather own OBDC's quality at a similar discount.
Active DOJ valuation probe + class actions + a 19% off-cycle markdown is an un-investable combination until the legal overhang clears. At $3.33 it trades ~53% below the (already cut) $7.07 NAV — the market is telling you it does not believe even the marked-down book. This is the poster child, not a bargain.
The timing is the scandal. The industry is pivoting toward retirement money with multi-decade lockups at the precise moment institutional retail is fleeing through 5% gates. Franklin Templeton's CEO admitted on live TV that private credit is "less liquid than people think" — while pitching it for 401(k)s. The same gate mechanics that trapped sophisticated LPs would apply with greater force to retirement savers who never understood the illiquidity terms. The Supreme Court's pending Anderson v. Intel (ERISA "meaningful benchmark") will shape how much litigation follows.
Downstream consequences: (1) The asset managers — OWL, BX, APO, ARES — get a new, stickier capital source that extends the cycle and supports fee streams even as institutional flows wobble; bullish for the GPs, structurally riskier for end-savers. (2) Expect a regulatory/political fight (Sen. Warren is already loud). (3) For your own money: if you have a 401(k), check whether your target-date fund is about to add an illiquid sleeve you can't redeem in a drawdown.
| Scenario | Prob. | Trigger | What it means |
|---|---|---|---|
| Base: orderly grind | 55% | Fitch PCDR plateaus ~5.5–6.5%; software losses absorbed by equity cushions; gates hold without fire sales | Quality BDC discounts narrow; OBDC/ARCC re-rate; FSK/TCPC stay cheap. Dispersion trade wins. |
| Bull: discount mean-reversion | 25% | Rates stabilize, spreads widen into new deals (lender-friendly), redemptions peak in Q2 then fade | OBDC to $13+, ARCC to $20+. The whole quality cohort re-rates toward NAV; +25–35% total return. |
| Bear: contagion & forced selling | 20% | A second consecutive quarter of breached gates; a marquee manager off-cycle markdown; DOJ charges; software maturity wall cracks early | NAVs reset 10–15% lower across the board; even quality discounts widen; avoid all, hold cash/T-bills. |
APO — I flagged Apollo a BUY at $130–138 on June 15 (target $165, 12mo). It's $136.60 today — squarely in the zone and working. The private-credit GPs are the structurally advantaged way to play the 401(k) retailization even as the BDC vehicles wobble; thesis intact, no change.
The marks underpinning a $1.7T asset class are breaking in public, and the equity market has done you a favor by repricing the listed vehicles ahead of the headlines. Don't paint the whole space with one brush. Own the quality discounts (OBDC my highest-conviction name here, ARCC the core), avoid the impaired (FSK/TCPC/MFIC), and watch the 401(k) pivot — it's the one development that both extends the cycle for the GPs and quietly transfers illiquidity risk onto savers who never signed up for it.